1. Home
  2. ISBA vs SLN Comparison

ISBA vs SLN Comparison

Compare ISBA & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISBA
  • SLN
  • Stock Information
  • Founded
  • ISBA 1903
  • SLN 1994
  • Country
  • ISBA United States
  • SLN United Kingdom
  • Employees
  • ISBA N/A
  • SLN N/A
  • Industry
  • ISBA
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ISBA
  • SLN Health Care
  • Exchange
  • ISBA NYSE
  • SLN Nasdaq
  • Market Cap
  • ISBA 248.8M
  • SLN 273.9M
  • IPO Year
  • ISBA N/A
  • SLN N/A
  • Fundamental
  • Price
  • ISBA $30.88
  • SLN $6.47
  • Analyst Decision
  • ISBA Hold
  • SLN Buy
  • Analyst Count
  • ISBA 1
  • SLN 5
  • Target Price
  • ISBA $28.00
  • SLN $32.60
  • AVG Volume (30 Days)
  • ISBA 36.3K
  • SLN 107.6K
  • Earning Date
  • ISBA 07-17-2025
  • SLN 08-14-2025
  • Dividend Yield
  • ISBA 3.63%
  • SLN N/A
  • EPS Growth
  • ISBA N/A
  • SLN N/A
  • EPS
  • ISBA 1.97
  • SLN N/A
  • Revenue
  • ISBA $70,307,000.00
  • SLN $27,701,000.00
  • Revenue This Year
  • ISBA $14.17
  • SLN N/A
  • Revenue Next Year
  • ISBA $7.95
  • SLN N/A
  • P/E Ratio
  • ISBA $15.68
  • SLN N/A
  • Revenue Growth
  • ISBA 4.06
  • SLN N/A
  • 52 Week Low
  • ISBA $17.55
  • SLN $1.97
  • 52 Week High
  • ISBA $44.99
  • SLN $22.47
  • Technical
  • Relative Strength Index (RSI)
  • ISBA N/A
  • SLN 64.49
  • Support Level
  • ISBA N/A
  • SLN $5.33
  • Resistance Level
  • ISBA N/A
  • SLN $6.55
  • Average True Range (ATR)
  • ISBA 0.00
  • SLN 0.44
  • MACD
  • ISBA 0.00
  • SLN 0.02
  • Stochastic Oscillator
  • ISBA 0.00
  • SLN 89.34

About ISBA ISABELLA BANK CORPORATION

Isabella Bank Corp is a U.S based financial service holding company. It offers banking services to businesses, institutions, and individuals. Its lending activities include loans made according to commercial and agricultural operating and real estate purposes, residential real estate loans, and consumer loans. Deposit services offered include checking accounts, savings accounts, certificates of deposit, direct deposits, cash management services, mobile and internet banking, electronic bill pay services and automated teller machines. The company also offers full-service trust and brokerage services.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: